Jeffrey Peacock, MD
Pain Medicine · Winston Salem, NCNPI 1811158439
Payments from drug & device makers
Across 464 payments — averaging $1191.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$432K
- Medtronic$117K
- Abbott$4K
- MML US, Inc.$115
- Globus Medical$96
- Nevro Corp.$35
- plus $100 from 4 others
Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$820
What the payments were for
- Consulting fees$3,85031%
- Travel & lodging$2,54020%
- Food & beverage$6,19649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 287 | $431,596 |
| Medtronic(2 entities) | 134 | $117,095 |
| Abbott | 30 | $3,704 |
| MML US, Inc. | 3 | $115 |
| Globus Medical | 3 | $96 |
| Nevro Corp. | 2 | $35 |
| Vertos Medical, Inc. | 1 | $32 |
| SPR Therapeutics, Inc | 2 | $30 |
| Avanos Medical | 1 | $23 |
| Nalu Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$552,741 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 168 | $3,266 |
| Lidocaine | 23 | $2,661 |
| Celecoxib | 205 | $2,544 |
| Pregabalin | 64 | $1,255 |
| Zonisamide | 24 | $1,126 |
| Methocarbamol | 85 | $1,121 |
| Tizanidine Hcl | 104 | $957 |
| Baclofen | 70 | $939 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $880 |
| Cephalexin | 79 | $482 |
| Tramadol Hcl | 42 | $355 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $347 |
| Diclofenac Sodium | 21 | $313 |
| Cyclobenzaprine Hcl | 55 | $310 |
| Nabumetone | 36 | $257 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Winston Salem
- Leonardo KapuralWinston Salem$4.1M
- James NorthWinston Salem$3.7M
- Richard RauckWinston Salem$1.7M
- Christopher GilmoreWinston Salem$1.3M
- Daniel BintrimWinston Salem$39K
- Lauren BeaverWinston Salem$11K
- Binit ShahHuntersville$863K
- Courtney AumanJacksonville$210K
- Javid BakshAsheville$202K
- David ZubLeland$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.